Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIR Trial of Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS (FSRS) for Intact Metastatic Brain Disease (FRACTIONATE)

NCT05222620 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05222620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05222620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIR Trial of Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS (FSRS) for Intact Metastatic Brain Disease (FRACTIONATE)
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
March 14, 2022
Completion date
August 1, 2027
Enrollment
90 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the brain, metastatic malignant solid neoplasm